5 Topic Commentaries

The Unmeasured Burden of Glaucoma: Part 2

The Unmeasured Burden of Glaucoma: Part 2

• 

  Gavin W. Roddy, MD, PhD

  Ophthalmology; Glaucoma

  •

  Mayo Clinic (Rochester, Minnesota)

  The only reliable treatment for GON (glaucomatous optic neuropathy) is lowering IOP (intraocular pressure) with medications, laser or surgery. Yet even when successful, these treatments may only delay progression, with side effects and repeated dosing leading to compliance issues and high economic burden.

  Source
• 

  Jella An, MD

  Ophthalmology; Glaucoma

  •

  Johns Hopkins Medicine, Wilmer Eye Institute

  They can be offered earlier in the disease and reduce the medication burdens for most patients.

  Source
• 

  Dustin D. French, PhD

  Health services research; Ophthalmology

  •

  Northwestern University Feinberg School of Medicine

  If nearly half of glaucoma patients aren’t getting the recommended follow-ups, that’s a serious failure in care. We need targeted solutions to ensure patients don’t slip through the cracks.

  Source
• 

  Ann Shue, MD

  Ophthalmology; Glaucoma

  •

  Stanford University School of Medicine, Department of Ophthalmology

  Access to care is a big problem with glaucoma patients.

  Source
• 

  Kyle Bolo, MD

  Ophthalmology; Glaucoma

  •

  Keck School of Medicine of USC, USC Roski Eye Institute

  A lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there’s less to save, and it’s harder to save what remains. That strongly motivates my research.

  Source